CompanyTrack
V

VESPULA THERAPEUTICS LTD

Active London

Research and experimental development on biotechnology

0 employees
Research and experimental development on biotechnology
V

VESPULA THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 5 Oct 2023 Active London, England 0 employees
Research and experimental development on biotechnology
Accounts Submitted 30 Jun 2025
Confirmation Statement Submitted 16 Oct 2025
Net assets £-553.86K
Total assets £0.00
Total Liabilities £-1.10M
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

86-90 Paul Street London EC2A 4NE England

Credit Report

Discover VESPULA THERAPEUTICS LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

N/A

Net Assets

-£553.86k

Total Liabilities

-£1.10M

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 10,000 Shares £10k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Oct 202410,000£10k£1

Officers

Officers

3 active 1 resigned
Status
Christoph HessDirectorSwissSwitzerland555 Oct 2023Active
Dmitry KuzminDirectorBritishEngland395 Oct 2023Active
Vasily FedorinDirectorBritishUnited Kingdom4227 Jan 2025Active

Shareholders

Shareholders (10)

University Of Basel
10.0%
6,25016 Oct 2025
Vasily Fedorin
1.0%
65516 Oct 2025
Natalie Johnston
0.5%
33016 Oct 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

4bio Ventures Ii L.p. Acting By Its General Partner 4bio Ventures Ii Gp Limited

United Kingdom

Active
Notified 5 Oct 2023
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

4BIO VENTURES II GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
4BIO PARTNERS LLP united kingdom
VESPULA THERAPEUTICS LTD Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
16 Oct 2025Confirmation StatementConfirmation statement made on 2025-10-04 with updatesView(4 pages)
30 Jun 2025AccountsAnnual accounts made up to 2024-10-31View(8 pages)
7 Feb 2025OfficersAppointment of Mr Vasily Fedorin as director on 2025-01-27View(2 pages)
7 Feb 2025OfficersTermination of Kyrylo Mudryy as director on 2025-01-27View(1 page)
17 Nov 2024ResolutionResolutionsView(5 pages)
16 Oct 2025 Confirmation Statement

Confirmation statement made on 2025-10-04 with updates

30 Jun 2025 Accounts

Annual accounts made up to 2024-10-31

7 Feb 2025 Officers

Appointment of Mr Vasily Fedorin as director on 2025-01-27

7 Feb 2025 Officers

Termination of Kyrylo Mudryy as director on 2025-01-27

17 Nov 2024 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 2025-10-04 with updates

4 months ago on 16 Oct 2025

Annual accounts made up to 2024-10-31

7 months ago on 30 Jun 2025

Appointment of Mr Vasily Fedorin as director on 2025-01-27

1 years ago on 7 Feb 2025

Termination of Kyrylo Mudryy as director on 2025-01-27

1 years ago on 7 Feb 2025

Resolutions

1 years ago on 17 Nov 2024